Episode 1, Part 3 of PharmTech AI Pulse Check covers why INTerpath-001's AI isn't ChatGPT and names pharma manufacturing's biggest AI governance gaps.
News|Articles|March 31, 2016
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-04-06-2016
- Volume 11
- Issue 4
CSafe Global Opens Atlanta Service Center
Author(s)Pharmaceutical Technology Editors
The service center will act as a hub for delivery, maintenance, calibration, and technical support for the company.
Advertisement
CSafe Global, a cold chain solution service provider, announced on March 29, 2016 the opening of a new service center in Atlanta, GA. Atlanta is the second of a total of seven new centers expected to open in 2016.
According to CSafe, the Atlanta service center will act as a hub for delivery, maintenance, calibration, and technical support. The company says the service center will assist in reducing delivery times, minimizing delivery charges, and eliminating Atlanta drop fees for final destination containers. Brian Kohr, president and CEO of CSafe, said in a press announcement that the new facility would allow the company to take advantage of the business growth from the capital improvement program underway at Hartsfield-Jackson Atlanta International Airport.
“This is another welcomed development for the company,” said Mark Mohr, director of customer support and partner management at CSafe, in a press announcement. “Atlanta has a rapidly growing life-science sector, is the world's busiest airport, and is a premier pharma-logistics hub.”
Source:
Articles in this issue
over 10 years ago
Fundamentals for Pharma Agility and ROIover 10 years ago
Specialty API Manufacturers Invest for Growthover 10 years ago
Identifying Relevant Crystalline Formsover 10 years ago
Going Global Increases API Monitoring Burdenover 10 years ago
U.S. Representatives Question the Safety of the Heparin Supplyover 10 years ago
Biopharmaceutical Outsourcing Continues to Growover 10 years ago
Article Details New 3D Modeling and Data Extraction Techniqueover 10 years ago
CMC Biologics and IDT Biologika Collaborate on ADC Manufacturingover 10 years ago
Vetter Breaks Ground on New Production Facilityover 10 years ago
AAI Pharma and Cambridge Major Laboratories Rebrand as AlcamiAdvertisement
Related to this article
Michael Levy, senior vice president, Digital & Innovation, USP, explains the digital supply chain in a preview of his upcoming CPHI Milan panel presentation, The Next Phase of Pharma Supply Chains.
FDA approves tavapadon, first D1/D5 agonist, validating AbbVie's $8.7B Cerevel deal and an October five-strength oral tablet launch.
Richard Jaenisch weighs how FDA's new NAM rule could reshape preclinical testing and what CMC teams should do now, on Manufacturing Intelligence.
In a preview of their panel discussion at AAPS PharmSci 360 2026, Alfred Rumondor, PhD, AbbVie, and Swita Singh, PhD, Bristol Myers Squibb, discuss the implementation of risk-based approaches for CMC.
Merck licenses SciBrunch's preclinical KRAS G12D inhibitor for $2.13B, raising tech transfer and scale-up questions for oral cancer drug development.
Ronald Piervincenzi, USP, urges drugmakers and purchasers to act on supply chain resilience to curb drug shortages and shape better policy.
Content on PharmTech.com this week ranged from fundamentals on the use of digital pathology in drug development, discussions on the use of AI in pharma, and regulatory actions impacting the industry.
Advertisement
Advertisement